Sun Pharmaceutical Industries Ltd Financials
Company Logo

Sun Pharmaceutical Industries Ltd Financial Statement

Sun Pharmaceutical Industries Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Mar 2025
Revenue7317.74
Operating Expense4196.28
Net Profit2000.46
Net Profit Margin27.34
Earning Per Share8.30
EBIDTA3121.46
Effective Tax Rate19.59

Sun Pharmaceutical Industries Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual20,275.17
Operating Expenses Annual14,775.28
Operating Profit Annual5,834.35
Interest Annual784.08
Depreciation1,600.62
Net Profit Annual2,858.18
Tax Annual591.47

Sun Pharmaceutical Industries Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning410.28
Cash Flow from Operations-292.42
Cash Flow from Investing-265.35
Cash Flow from Financing473.95
Cash Flow at the End326.46

Sun Pharmaceutical Industries Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)28.78
PBIT Margin (%)20.88
PBT Margin (%)20.85
Net PROFIT Margin (%)14.10
Return On Networth / Equity (%)12.05
Return On Networth /Employed (%)12.22
Return On Assets (%)8.32
Total Debt / Equity (X)0.40
Asset Turnover Ratio (%)0.59

Sun Pharmaceutical Industries Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual8,114.61
Total Current Assets Annual14,912.54
Non Current Assets Annual26,110.38
Total Shareholders Funds Annual23,694.40
Total Assets Annual41,064.79

Sun Pharmaceutical Industries Ltd Earning Calls

EPS (INR)

Expected

8.96

Reported

9.00

Surprise

0.45%

Dec 2024

EPS beaten by 0.45%

Sep 2024

EPS beaten by 0.00%

Jun 2024

EPS beaten by 0.24%

FAQS on Sun Pharmaceutical Industries Ltd Financials

As of Jun 7, 2025, Sun Pharmaceutical Industries Ltd has a market capitalization of 4,16,392.59 Cr. Value Research classifies it as a Mega-Cap company.

Yes, Sun Pharmaceutical Industries Ltd is with a debt-to-equity ratio of 0.46.

In FY 2024 , Sun Pharmaceutical Industries Ltd recorded a total revenue of approximately 22,625.88 Cr marking a significant milestone in the company's financial performance.

Sun Pharmaceutical Industries Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.3% and 0.1% annually, respectively..

Sun Pharmaceutical Industries Ltd's current PE ratio is 97.23.

Sun Pharmaceutical Industries Ltd's ROCE averaged 14.7% from the FY ending March 2023 to 2025, with a median of 15.9%. It peaked at 16.5% in March 2025, reflecting strong capital efficiency over the period..

Sun Pharmaceutical Industries Ltd's latest EBIT is Rs. 5,923.78 Cr, surpassing the average EBIT of Rs. 4,123.58 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions